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Background
Type 2 diabetes (T2D) is an independent risk factor for
adverse cardiac events, such as hypertension and myocar-
dial infarction. The underlying biochemical changes asso-
ciated with diabetes have been shown to increase collagen
deposition and cross-linking, which may lead to micro-
scopic alterations in the myocardial structure that precede
measurable changes in cardiac function. Non-invasive
imaging methods are important for risk stratification of
asymptomatic patients and to gain a better understanding
of the pathophysiology of diabetic heart disease. T1
mapping is a novel Cardiovascular Magnetic Resonance
Imaging (CMR) technique for quantification of increased
extracellular volume fraction that occurs with diffuse
collagen replacement. The objective of this research is to
examine post-contrast myocardial T1 values in asympto-
matic T2D patients.
Methods
Patients diagnosed with type 2 diabetes (HbA1c 7.5-9.9%;
mean age 53±8; n=10), and healthy, non-diabetic age-
matched controls (mean age 47±10; n=10) were assessed at
the Stephenson CMR Centre in Calgary using a clinical 1.5 T
scanner. Medical history and ECG were reviewed to rule out
ischemic heart disease. Eligible patients underwent a CMR
scan including quantitative T1 mapping (SASHA) before and
15 minutes after 0.15 mmol/kg of Gd-DTPA (Magnevist)
contrast injection, with subsequent evaluation of mid and
basal slices for segment and global T1 values (Figure 1).
Additionally, standard CMR protocols were used to assess
function, and Late Gadolinium Enhancement (LGE).
Results
A significant difference in post-contrast myocardial T1
values was observed in patients as compared to controls
(580 ± 54 and 623 ± 31 ms; p < 0.05). No significant differ-
ences in functional parameters were found between
patients and controls; both had normal systolic function
(LV ejection fraction 57.9 ± 2.6 and 57.8 ± 2.9%, respec-
tively), although T2D patients had a slightly reduced
indexed LV end diastolic volumes. No regional areas of
LGE were detected in either group.
Conclusions
The observed decrease in T1 mapping times reflect an
increased extracellular volume fraction, and may reflect
globally increased collagen deposition in diabetic myo-
cardium. This finding compliments previous findings by
this group of preclinical changes in microvascular func-
tion in diabetes. Further studies are required to assess
the pathophysiologic context and prognostic impact.
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Figure 1 Myocardial segment plot of post-contrast myocardial T1
values in a diabetes patient, showing basal and mid slice with an
overall average T1 value of 562±33 ms.
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